Oncology drug shortages in the USA - business as usual

Nat Rev Clin Oncol. 2020 Mar;17(3):128-129. doi: 10.1038/s41571-019-0318-x.

Authors

Erin R Fox¹, Yoram Unguru²

Affiliations

¹ Drug Information and Support Services, Department of Pharmacotherapy, University of Utah Health and University of Utah College of Pharmacy, Salt Lake City, UT, USA. erin.fox@hsc.utah.edu.
² Division of Pediatric Hematology / Oncology, The Herman and Walter Samuelson Children's Hospital at Sinai and Johns Hopkins University Berman Institute of Bioethics, Baltimore, MD, USA. yunguru@lifebridgehealth.org.

PMID: 31831853
DOI: 10.1038/s41571-019-0318-x

No abstract available

MeSH terms

Antineoplastic Agents / therapeutic use*
Drug Industry*
Humans
Medical Oncology
Neoplasms / drug therapy*
Neoplasms / epidemiology
United States / epidemiology

Substances

Antineoplastic Agents